Deyaa Adib
Impact in
-
- Lymphoma Diagnosis and Treatment
-
- Chronic Lymphocytic Leukemia Research
Papers in
-
- Lymphoma Diagnosis and Treatment 8
-
- Cancer-related gene regulation 7
- Epigenetics and DNA Methylation 4
- Protein Degradation and Inhibitors 2
- Co-authors
- Franck Morschhauser (6 shared papers)Pam McKay (4 shared papers)Hervé Tilly (3 shared papers)Tycel Phillips (4 shared papers)Anand Rajarethinam (3 shared papers)Stephen Opat (3 shared papers)Vincent Ribrag (3 shared papers)Gilles Salles (4 shared papers)
- Journals
- Blood (5 papers)Journal of Clinical Oncology (3 papers)Advances in Therapy (1 paper)Annals of Oncology (1 paper)Hematological Oncology (1 paper)
- Partner nations
- United StatesFranceUnited Kingdom
In The Last Decade
Deyaa Adib
16 papers receiving 86 citations
Peers
Comparison fields: 5 of 22
- Pathology and Forensic Medicine 37
- Genetics 13
- Oncology 30
- Immunology 16
- Cancer Research 9
Countries citing papers authored by Deyaa Adib
This map shows the geographic impact of Deyaa Adib's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Deyaa Adib with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Deyaa Adib more than expected).
Fields of papers citing papers by Deyaa Adib
This network shows the impact of papers produced by Deyaa Adib. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Deyaa Adib. The network helps show where Deyaa Adib may publish in the future.
Co-authors
The 25 scholars most cited alongside Deyaa Adib, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 29 | |
| 2 | 2018 | 16 | |
| 3 | 2019 | 10 | |
| 4 | 2015 | 6 | |
| 5 | 2021 | 5 | |
| 6 | 2022 | 5 | |
| 7 | 2015 | 5 | |
| 8 | 2021 | 2 | |
| 9 | 2023 | 1 | |
| 10 | 2021 | 1 | |
| 11 | 2020 | 1 | |
| 12 | 2020 | 1 | |
| 13 | 2023 | 1 | |
| 14 | 2023 | 1 | |
| 15 | 2017 | 1 | |
| 16 | 2020 | 1 |
About Deyaa Adib
Deyaa Adib is a scholar working on Pathology and Forensic Medicine, Molecular Biology, Oncology, Immunology and Cellular and Molecular Neuroscience, having authored 16 papers that have together received 86 indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (8 papers), Cancer-related gene regulation (7 papers), Epigenetics and DNA Methylation (4 papers), Cancer Immunotherapy and Biomarkers (3 papers), CAR-T cell therapy research (3 papers), Prostate Cancer Treatment and Research (2 papers), Protein Degradation and Inhibitors (2 papers) and Macrophage Migration Inhibitory Factor (2 papers). The work is most often cited by research in Pathology and Forensic Medicine (37 citations), Genetics (13 citations), Oncology (30 citations), Immunology (16 citations) and Cancer Research (9 citations). Deyaa Adib has collaborated with scholars based in United States, France and United Kingdom. Frequent co-authors include Franck Morschhauser, Pam McKay, Hervé Tilly, Tycel Phillips, Anand Rajarethinam, Stephen Opat, Vincent Ribrag, Gilles Salles, John Radford and Jay Yang. Their work appears in journals such as Blood, Journal of Clinical Oncology, Advances in Therapy, Annals of Oncology and Hematological Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.